These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19141740)

  • 1. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany.
    Asmah N; Eberspächer B; Regnath T; Arvand M
    J Med Microbiol; 2009 Feb; 58(Pt 2):222-227. PubMed ID: 19141740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE; Wagner J; Arvand M
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
    Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
    Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)].
    Campelo FA; Pedrosa AC; Antúnez IÁ; Capuz BL
    Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
    Chen I; Kaufisi P; Erdem G
    J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Phenotypic and Molecular Methods for Identification of Species within the Streptococcus anginosus Group.
    Arinto-Garcia R; Pinho MD; Carriço JA; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2015 Nov; 53(11):3580-8. PubMed ID: 26354817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.
    Florindo C; Viegas S; Paulino A; Rodrigues E; Gomes JP; Borrego MJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1458-63. PubMed ID: 19886900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate.
    Gravey F; Galopin S; Grall N; Auzou M; Andremont A; Leclercq R; Cattoir V
    J Antimicrob Chemother; 2013 Nov; 68(11):2464-7. PubMed ID: 23812683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin-Susceptible but Clindamycin-Resistant Phenotype of Clinical ermB-PCR-Positive Group B Streptococci Isolates with IS1216E-Inserted ermB.
    Moroi H; Kimura K; Ido A; Banno H; Jin W; Wachino JI; Yamada K; Kikkawa F; Park YJ; Arakawa Y
    Jpn J Infect Dis; 2019 Nov; 72(6):420-422. PubMed ID: 31257242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, clinical aspects, susceptibility pattern, and molecular epidemiology of beta-haemolytic group G Streptococcus anginosus group isolates from central Taiwan.
    Chang YC; Lo HH
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):262-5. PubMed ID: 23632249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications.
    Abraham T; Sistla S
    Indian J Med Microbiol; 2018; 36(2):186-191. PubMed ID: 30084408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
    Yan JJ; Wu HM; Huang AH; Fu HM; Lee CT; Wu JJ
    J Clin Microbiol; 2000 Jul; 38(7):2475-9. PubMed ID: 10878028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
    Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
    J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.
    Dutra VG; Alves VM; Olendzki AN; Dias CA; de Bastos AF; Santos GO; de Amorin EL; Sousa MÂ; Santos R; Ribeiro PC; Fontes CF; Andrey M; Magalhães K; Araujo AA; Paffadore LF; Marconi C; Murta EF; Fernandes PC; Raddi MS; Marinho PS; Bornia RB; Palmeiro JK; Dalla-Costa LM; Pinto TC; Botelho AC; Teixeira LM; Fracalanzza SE
    BMC Infect Dis; 2014 Jun; 14():323. PubMed ID: 24919844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.